Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEMOLIZUMAB vs NEOMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NEMOLIZUMAB vs NEOMYCIN: Safety Overview

Metric NEMOLIZUMAB NEOMYCIN
Total FAERS Reports 371 1,515
Deaths Reported 54 724
Death Rate 14.6% 47.8%
Hospitalizations 136 801
Average Patient Age 63.9 yrs 50.7 yrs
% Female Patients 37.5% 92.7%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Galderma Laboratories, L.P. Target Corporation
Route SUBCUTANEOUS TOPICAL
Marketing Status N/A Discontinued